US Stock MarketDetailed Quotes

CERO CERo Therapeutics

Watchlist
  • 0.918
  • -0.022-2.37%
Close May 24 16:00 ET
  • 0.920
  • +0.002+0.24%
Post 19:55 ET
13.82MMarket Cap-1854P/E (TTM)

CERo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
-14.75%4.59M
--5.39M
-64.51%6.82M
--19.22M
-Cash and cash equivalents
-14.75%4.59M
--5.39M
-64.51%6.82M
--19.22M
Receivables
--162.06K
----
----
----
-Other receivables
--162.06K
----
----
----
Other current assets
348.45%746.05K
--166.36K
-16.20%256.46K
--306.05K
Total current assets
-0.96%5.5M
--5.55M
-63.76%7.08M
--19.52M
Non current assets
Net PPE
-28.30%2.87M
--4M
-8.14%4.27M
--4.65M
-Gross PPE
-12.83%4.57M
--5.24M
1.84%5.4M
--5.3M
-Accumulated depreciation
-36.94%-1.7M
---1.24M
-73.17%-1.13M
---650.89K
Non current deferred assets
--683.35K
----
----
----
Total non current assets
-11.21%3.55M
--4M
-8.14%4.27M
--4.65M
Total assets
-5.25%9.05M
--9.55M
-53.05%11.35M
--24.18M
Liabilities
Current liabilities
Payables
721.55%7.14M
--868.86K
-14.94%391.19K
--459.92K
-accounts payable
712.52%7.06M
--868.86K
-14.94%391.19K
--459.92K
-Total tax payable
--78.45K
----
----
----
Current accrued expenses
-62.74%92.88K
--249.25K
180.22%80.64K
--28.78K
Current debt and capital lease obligation
72.13%1.2M
--695.63K
14.89%672.37K
--585.25K
-Current debt
--402.51K
----
----
----
-Current capital lease obligation
14.27%794.89K
--695.63K
14.89%672.37K
--585.25K
Other current liabilities
--3.1M
----
----
----
Current liabilities
506.77%11.65M
--1.92M
-36.68%1.16M
--1.84M
Non current liabilities
Long term debt and capital lease obligation
-36.78%1.37M
--2.16M
-22.29%2.34M
--3.02M
-Long term capital lease obligation
-36.78%1.37M
--2.16M
-22.29%2.34M
--3.02M
Non current deferred liabilities
--13.72K
----
----
----
Derivative product liabilities
----
--647.04K
-5.71%610.38K
--647.37K
Preferred securities outside stock equity
--0
--42.1M
0.00%42.1M
--42.1M
Total non current liabilities
-96.93%1.38M
--44.91M
-1.55%45.06M
--45.77M
Total liabilities
-72.17%13.03M
--46.83M
-2.91%46.22M
--47.6M
Shareholders'equity
Share capital
1,041,765.78%9.44M
--906
0.78%904
--897
-common stock
60.26%1.45K
--906
0.78%904
--897
-Preferred stock
--9.44M
----
----
----
Retained earnings
-69.76%-64.91M
---38.24M
-49.35%-35.8M
---23.97M
Paid-in capital
5,513.52%53.99M
--961.87K
71.36%928.56K
--541.87K
Other equity interest
---2.5M
----
----
----
Total stockholders'equity
89.33%-3.98M
---37.28M
-48.84%-34.87M
---23.43M
Total equity
89.33%-3.98M
---37.28M
-48.84%-34.87M
---23.43M
Currency Unit
USD
USD
USD
USD
(Q1)Mar 31, 2024(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments -14.75%4.59M--5.39M-64.51%6.82M--19.22M
-Cash and cash equivalents -14.75%4.59M--5.39M-64.51%6.82M--19.22M
Receivables --162.06K------------
-Other receivables --162.06K------------
Other current assets 348.45%746.05K--166.36K-16.20%256.46K--306.05K
Total current assets -0.96%5.5M--5.55M-63.76%7.08M--19.52M
Non current assets
Net PPE -28.30%2.87M--4M-8.14%4.27M--4.65M
-Gross PPE -12.83%4.57M--5.24M1.84%5.4M--5.3M
-Accumulated depreciation -36.94%-1.7M---1.24M-73.17%-1.13M---650.89K
Non current deferred assets --683.35K------------
Total non current assets -11.21%3.55M--4M-8.14%4.27M--4.65M
Total assets -5.25%9.05M--9.55M-53.05%11.35M--24.18M
Liabilities
Current liabilities
Payables 721.55%7.14M--868.86K-14.94%391.19K--459.92K
-accounts payable 712.52%7.06M--868.86K-14.94%391.19K--459.92K
-Total tax payable --78.45K------------
Current accrued expenses -62.74%92.88K--249.25K180.22%80.64K--28.78K
Current debt and capital lease obligation 72.13%1.2M--695.63K14.89%672.37K--585.25K
-Current debt --402.51K------------
-Current capital lease obligation 14.27%794.89K--695.63K14.89%672.37K--585.25K
Other current liabilities --3.1M------------
Current liabilities 506.77%11.65M--1.92M-36.68%1.16M--1.84M
Non current liabilities
Long term debt and capital lease obligation -36.78%1.37M--2.16M-22.29%2.34M--3.02M
-Long term capital lease obligation -36.78%1.37M--2.16M-22.29%2.34M--3.02M
Non current deferred liabilities --13.72K------------
Derivative product liabilities ------647.04K-5.71%610.38K--647.37K
Preferred securities outside stock equity --0--42.1M0.00%42.1M--42.1M
Total non current liabilities -96.93%1.38M--44.91M-1.55%45.06M--45.77M
Total liabilities -72.17%13.03M--46.83M-2.91%46.22M--47.6M
Shareholders'equity
Share capital 1,041,765.78%9.44M--9060.78%904--897
-common stock 60.26%1.45K--9060.78%904--897
-Preferred stock --9.44M------------
Retained earnings -69.76%-64.91M---38.24M-49.35%-35.8M---23.97M
Paid-in capital 5,513.52%53.99M--961.87K71.36%928.56K--541.87K
Other equity interest ---2.5M------------
Total stockholders'equity 89.33%-3.98M---37.28M-48.84%-34.87M---23.43M
Total equity 89.33%-3.98M---37.28M-48.84%-34.87M---23.43M
Currency Unit USDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg